APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell-free DNA Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell-free DNA Testing Service Market Analysis and Forecast 2026-2032

8 January 2026196 pages

Choose your research edition.

Industry ResearchCell-free DNA Testing Service Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell-free DNA Testing Service Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Cell-free DNA Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell-free DNA Testing Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell-free DNA Testing Service Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cell-free DNA Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell-free DNA Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell-free DNA Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell-free DNA Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell-free DNA Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell-free DNA Testing Service include Natera, Revvity, CareDx, BillionToOne, Inc., ARUP Laboratories, Illumina, Yourgene Health, Oncogenomics and Roche, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell-free DNA Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell-free DNA Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell-free DNA Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell-free DNA Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell-free DNA Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell-free DNA Testing Service revenue, projected growth trends, production technology, application and end-user industry.

Cell-free DNA Testing Service Segment by Company

Natera

Revvity

CareDx

BillionToOne, Inc.

ARUP Laboratories

Illumina

Yourgene Health

Oncogenomics

Roche

Cell-free DNA Testing Service Segment by Type

Targeted Sequencing

Whole Genome Sequencing

Cell-free DNA Testing Service Segment by Application

Prenatal Testing

Oncology

Organ Transplant Monitoring

Others

Cell-free DNA Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell-free DNA Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell-free DNA Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell-free DNA Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell-free DNA Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell-free DNA Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell-free DNA Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell-free DNA Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Targeted Sequencing Major Player Table 3. Whole Genome Sequencing Major Player Table 4. Global Cell-free DNA Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Prenatal Testing Major Player Table 6. Oncology Major Player Table 7. Organ Transplant Monitoring Major Player Table 8. Others Major Player Table 9. Cell-free DNA Testing Service Industry Trends Table 10. Cell-free DNA Testing Service Industry Drivers Table 11. Cell-free DNA Testing Service Industry Opportunities and Challenges Table 12. Cell-free DNA Testing Service Industry Restraints Table 13. Global Cell-free DNA Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cell-free DNA Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cell-free DNA Testing Service Market Share by Region (2021-2026) Table 16. Global Cell-free DNA Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cell-free DNA Testing Service Market Share by Region (2027-2032) Table 18. Global Cell-free DNA Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cell-free DNA Testing Service Revenue Market Share by Players (2021-2026) Table 20. Global Cell-free DNA Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cell-free DNA Testing Service Key Players Headquarters & Area Served Table 22. Global Cell-free DNA Testing Service Players, Product Type & Application Table 23. Global Cell-free DNA Testing Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cell-free DNA Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cell-free DNA Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cell-free DNA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cell-free DNA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cell-free DNA Testing Service Revenue Market Share by Type (2021-2026) Table 30. Global Cell-free DNA Testing Service Revenue Market Share by Type (2027-2032) Table 31. Global Cell-free DNA Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cell-free DNA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cell-free DNA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cell-free DNA Testing Service Revenue Market Share by Application (2021-2026) Table 35. Global Cell-free DNA Testing Service Revenue Market Share by Application (2027-2032) Table 36. Natera Company Information Table 37. Natera Business Overview Table 38. Natera Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Natera Cell-free DNA Testing Service Product Portfolio Table 40. Natera Recent Development Table 41. Revvity Company Information Table 42. Revvity Business Overview Table 43. Revvity Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Revvity Cell-free DNA Testing Service Product Portfolio Table 45. Revvity Recent Development Table 46. CareDx Company Information Table 47. CareDx Business Overview Table 48. CareDx Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. CareDx Cell-free DNA Testing Service Product Portfolio Table 50. CareDx Recent Development Table 51. BillionToOne, Inc. Company Information Table 52. BillionToOne, Inc. Business Overview Table 53. BillionToOne, Inc. Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. BillionToOne, Inc. Cell-free DNA Testing Service Product Portfolio Table 55. BillionToOne, Inc. Recent Development Table 56. ARUP Laboratories Company Information Table 57. ARUP Laboratories Business Overview Table 58. ARUP Laboratories Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. ARUP Laboratories Cell-free DNA Testing Service Product Portfolio Table 60. ARUP Laboratories Recent Development Table 61. Illumina Company Information Table 62. Illumina Business Overview Table 63. Illumina Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Illumina Cell-free DNA Testing Service Product Portfolio Table 65. Illumina Recent Development Table 66. Yourgene Health Company Information Table 67. Yourgene Health Business Overview Table 68. Yourgene Health Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Yourgene Health Cell-free DNA Testing Service Product Portfolio Table 70. Yourgene Health Recent Development Table 71. Oncogenomics Company Information Table 72. Oncogenomics Business Overview Table 73. Oncogenomics Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Oncogenomics Cell-free DNA Testing Service Product Portfolio Table 75. Oncogenomics Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Cell-free DNA Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Roche Cell-free DNA Testing Service Product Portfolio Table 80. Roche Recent Development Table 81. North America Cell-free DNA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Cell-free DNA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Cell-free DNA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Cell-free DNA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Cell-free DNA Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Cell-free DNA Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 87. North America Cell-free DNA Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 88. Europe Cell-free DNA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Cell-free DNA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Cell-free DNA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Cell-free DNA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Cell-free DNA Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Cell-free DNA Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 94. Europe Cell-free DNA Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 95. China Cell-free DNA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 96. China Cell-free DNA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 97. China Cell-free DNA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 98. China Cell-free DNA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia Cell-free DNA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 100. Asia Cell-free DNA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 101. Asia Cell-free DNA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 102. Asia Cell-free DNA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Cell-free DNA Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Cell-free DNA Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 105. Asia Cell-free DNA Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 106. SAMEA Cell-free DNA Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 107. SAMEA Cell-free DNA Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 108. SAMEA Cell-free DNA Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 109. SAMEA Cell-free DNA Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 110. SAMEA Cell-free DNA Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. SAMEA Cell-free DNA Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 112. SAMEA Cell-free DNA Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Cell-free DNA Testing Service Image Figure 2. Global Cell-free DNA Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell-free DNA Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Targeted Sequencing Image Figure 5. Whole Genome Sequencing Image Figure 6. Global Cell-free DNA Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cell-free DNA Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Prenatal Testing Image Figure 9. Oncology Image Figure 10. Organ Transplant Monitoring Image Figure 11. Others Image Figure 12. Global Cell-free DNA Testing Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Cell-free DNA Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cell-free DNA Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cell-free DNA Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cell-free DNA Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cell-free DNA Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cell-free DNA Testing Service Revenue Market Share by Type (2021-2032) Figure 20. Global Cell-free DNA Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cell-free DNA Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cell-free DNA Testing Service Revenue Market Share by Application (2021-2032) Figure 23. North America Cell-free DNA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cell-free DNA Testing Service Revenue Share by Type (2021-2032) Figure 25. North America Cell-free DNA Testing Service Revenue Share by Application (2021-2032) Figure 26. North America Cell-free DNA Testing Service Revenue Share by Country (2021-2032) Figure 27. United States Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cell-free DNA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cell-free DNA Testing Service Revenue Share by Type (2021-2032) Figure 32. Europe Cell-free DNA Testing Service Revenue Share by Application (2021-2032) Figure 33. Europe Cell-free DNA Testing Service Revenue Share by Country (2021-2032) Figure 34. Germany Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cell-free DNA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cell-free DNA Testing Service Revenue Share by Type (2021-2032) Figure 44. China Cell-free DNA Testing Service Revenue Share by Application (2021-2032) Figure 45. Asia Cell-free DNA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cell-free DNA Testing Service Revenue Share by Type (2021-2032) Figure 47. Asia Cell-free DNA Testing Service Revenue Share by Application (2021-2032) Figure 48. Asia Cell-free DNA Testing Service Revenue Share by Region (2021-2032) Figure 49. Japan Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cell-free DNA Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cell-free DNA Testing Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Cell-free DNA Testing Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Cell-free DNA Testing Service Revenue Share by Country (2021-2032) Figure 59. Brazil Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cell-free DNA Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing
  • Whole Genome Sequencing
Applications
  • Prenatal Testing
  • Oncology
  • Organ Transplant Monitoring
  • Others
Companies covered
  • Natera
  • Revvity
  • CareDx
  • BillionToOne, Inc.
  • ARUP Laboratories
  • Illumina
  • Yourgene Health
  • Oncogenomics
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell-free DNA Testing Service Market by Type
  3. 1.2.1 Global Cell-free DNA Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Sequencing
  5. 1.2.3 Whole Genome Sequencing
  6. 1.3 Cell-free DNA Testing Service Market by Application
  7. 1.3.1 Global Cell-free DNA Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Prenatal Testing
  9. 1.3.3 Oncology
  10. 1.3.4 Organ Transplant Monitoring
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cell-free DNA Testing Service Market Dynamics
  1. 2.1 Cell-free DNA Testing Service Industry Trends
  2. 2.2 Cell-free DNA Testing Service Industry Drivers
  3. 2.3 Cell-free DNA Testing Service Industry Opportunities and Challenges
  4. 2.4 Cell-free DNA Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell-free DNA Testing Service Market Perspective (2021-2032)
  2. 3.2 Global Cell-free DNA Testing Service Growth Trends by Region
  3. 3.2.1 Global Cell-free DNA Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell-free DNA Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell-free DNA Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell-free DNA Testing Service Revenue by Players
  2. 4.1.1 Global Cell-free DNA Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell-free DNA Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell-free DNA Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell-free DNA Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell-free DNA Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global Cell-free DNA Testing Service Players, Product Type & Application
  8. 4.5 Global Cell-free DNA Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell-free DNA Testing Service Market CR5 and HHI
  11. 4.6.3 2025 Cell-free DNA Testing Service Tier 1, Tier 2, and Tier 3
5 Cell-free DNA Testing Service Market Size by Type
  1. 5.1 Global Cell-free DNA Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell-free DNA Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global Cell-free DNA Testing Service Revenue Market Share by Type (2021-2032)
6 Cell-free DNA Testing Service Market Size by Application
  1. 6.1 Global Cell-free DNA Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell-free DNA Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global Cell-free DNA Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Natera
  2. 7.1.1 Natera Company Information
  3. 7.1.2 Natera Business Overview
  4. 7.1.3 Natera Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Natera Cell-free DNA Testing Service Product Portfolio
  6. 7.1.5 Natera Recent Developments
  7. 7.2 Revvity
  8. 7.2.1 Revvity Company Information
  9. 7.2.2 Revvity Business Overview
  10. 7.2.3 Revvity Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Revvity Cell-free DNA Testing Service Product Portfolio
  12. 7.2.5 Revvity Recent Developments
  13. 7.3 CareDx
  14. 7.3.1 CareDx Company Information
  15. 7.3.2 CareDx Business Overview
  16. 7.3.3 CareDx Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 CareDx Cell-free DNA Testing Service Product Portfolio
  18. 7.3.5 CareDx Recent Developments
  19. 7.4 BillionToOne, Inc.
  20. 7.4.1 BillionToOne, Inc. Company Information
  21. 7.4.2 BillionToOne, Inc. Business Overview
  22. 7.4.3 BillionToOne, Inc. Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BillionToOne, Inc. Cell-free DNA Testing Service Product Portfolio
  24. 7.4.5 BillionToOne, Inc. Recent Developments
  25. 7.5 ARUP Laboratories
  26. 7.5.1 ARUP Laboratories Company Information
  27. 7.5.2 ARUP Laboratories Business Overview
  28. 7.5.3 ARUP Laboratories Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ARUP Laboratories Cell-free DNA Testing Service Product Portfolio
  30. 7.5.5 ARUP Laboratories Recent Developments
  31. 7.6 Illumina
  32. 7.6.1 Illumina Company Information
  33. 7.6.2 Illumina Business Overview
  34. 7.6.3 Illumina Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Illumina Cell-free DNA Testing Service Product Portfolio
  36. 7.6.5 Illumina Recent Developments
  37. 7.7 Yourgene Health
  38. 7.7.1 Yourgene Health Company Information
  39. 7.7.2 Yourgene Health Business Overview
  40. 7.7.3 Yourgene Health Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Yourgene Health Cell-free DNA Testing Service Product Portfolio
  42. 7.7.5 Yourgene Health Recent Developments
  43. 7.8 Oncogenomics
  44. 7.8.1 Oncogenomics Company Information
  45. 7.8.2 Oncogenomics Business Overview
  46. 7.8.3 Oncogenomics Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Oncogenomics Cell-free DNA Testing Service Product Portfolio
  48. 7.8.5 Oncogenomics Recent Developments
  49. 7.9 Roche
  50. 7.9.1 Roche Company Information
  51. 7.9.2 Roche Business Overview
  52. 7.9.3 Roche Cell-free DNA Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Roche Cell-free DNA Testing Service Product Portfolio
  54. 7.9.5 Roche Recent Developments
8 North America
  1. 8.1 North America Cell-free DNA Testing Service Revenue (2021-2032)
  2. 8.2 North America Cell-free DNA Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell-free DNA Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell-free DNA Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America Cell-free DNA Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell-free DNA Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell-free DNA Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell-free DNA Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America Cell-free DNA Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell-free DNA Testing Service Revenue by Country
  11. 8.6.1 North America Cell-free DNA Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell-free DNA Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell-free DNA Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell-free DNA Testing Service Revenue (2021-2032)
  2. 9.2 Europe Cell-free DNA Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell-free DNA Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell-free DNA Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Cell-free DNA Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell-free DNA Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell-free DNA Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell-free DNA Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Cell-free DNA Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell-free DNA Testing Service Revenue by Country
  11. 9.6.1 Europe Cell-free DNA Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell-free DNA Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell-free DNA Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell-free DNA Testing Service Revenue (2021-2032)
  2. 10.2 China Cell-free DNA Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Cell-free DNA Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Cell-free DNA Testing Service Revenue by Type (2027-2032)
  5. 10.3 China Cell-free DNA Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Cell-free DNA Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Cell-free DNA Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Cell-free DNA Testing Service Revenue by Application (2027-2032)
  9. 10.5 China Cell-free DNA Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell-free DNA Testing Service Revenue (2021-2032)
  2. 11.2 Asia Cell-free DNA Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell-free DNA Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell-free DNA Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Cell-free DNA Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell-free DNA Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell-free DNA Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell-free DNA Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Cell-free DNA Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell-free DNA Testing Service Revenue by Country
  11. 11.6.1 Asia Cell-free DNA Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell-free DNA Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell-free DNA Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell-free DNA Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA Cell-free DNA Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell-free DNA Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell-free DNA Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell-free DNA Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell-free DNA Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell-free DNA Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell-free DNA Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell-free DNA Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell-free DNA Testing Service Revenue by Country
  11. 12.6.1 SAMEA Cell-free DNA Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell-free DNA Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell-free DNA Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst